MAPT and Alzheimer disease: As the field continues to evolve, these insights will be crucial in guiding the future of AD treatment, particularly in the pursuit of therapies that not only reduce amyloid and tau pathologies but also address the broader inflammatory processes that contribute to neurodegeneration (22).